S235: A TWO-PART, SINGLE- AND TWO-ARM RANDOMIZED, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE S1P RECEPTOR MODULATOR KRP203 IN SUBJECTS WITH HEMATOLOGICAL MALIGNANCIES
S. dertschnig,
J. finke,
D. heim,
U. schanz,
E. holler,
U. holtick,
G. socié,
T. teshima,
C. bucher,
J. passweg
Affiliations
S. dertschnig
1 Priothera SAS, Saint Louis, France
J. finke
2 Heamtology, Oncology and SCT, University Freiburg, Freiburg, Germany
D. heim
3 Hematology, University Hosptial Basel, Basel
U. schanz
4 University Hospital Zürich, Zürich, Switzerland
E. holler
5 Klinik und Poliklinik Innere Medizin III, Unuversitätsklinikum Regensburg, Regensburg
U. holtick
6 Klinik I für Innere Medizin, Köln, Germany
G. socié
7 Saint Louis Hospital, Paris, France
T. teshima
8 Hokkaido University, Faculty of Medicine, Sapporo, Japan
